home / stock / lexxw / lexxw quote
Last: | $1.35 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.35 |
High: | $0 |
Low: | $0 |
Volume: | 68 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.35 | $0 | $1.35 | $0 | $0 | 68 | 05-14-2024 |
$1.35 | $0 | $1.35 | $0 | $0 | 64 | 05-13-2024 |
$1.35 | $1.35 | $1.35 | $1.35 | $1.34 | 35,321 | 05-10-2024 |
$1.2499 | $1.01 | $1.2499 | $1.27 | $1.01 | 2,122 | 05-09-2024 |
$1.1 | $0 | $1.1 | $0 | $0 | 1 | 05-08-2024 |
$1.1 | $1.08 | $1.1 | $1.1 | $0.98 | 105,202 | 05-07-2024 |
$0.8199 | $0.84 | $0.8199 | $0.84 | $0.7846 | 2,327 | 05-06-2024 |
$1.0994 | $1.1 | $1.0994 | $1.1 | $1.09 | 3,000 | 05-03-2024 |
$1.1999 | $1.1076 | $1.1999 | $1.1999 | $0.75 | 1,924 | 05-02-2024 |
$1.11 | $1.01 | $1.11 | $1.15 | $1.01 | 3,141 | 05-01-2024 |
$0.9816 | $0.75 | $0.9816 | $1.11 | $0.75 | 2,685 | 04-30-2024 |
$0.75 | $0.8054 | $0.75 | $0.85 | $0.75 | 349,400 | 04-29-2024 |
$0.7996 | $0.73 | $0.7996 | $0.9747 | $0.7099 | 264,457 | 04-26-2024 |
$0.71 | $0.71 | $0.71 | $0.71 | $0.71 | 100 | 04-25-2024 |
$0.5111 | $0.884 | $0.5111 | $0.884 | $0.5111 | 4,610 | 04-24-2024 |
$0.76 | $0.76 | $0.76 | $0.76 | $0.76 | 195 | 04-23-2024 |
$0.92 | $0.95 | $0.92 | $0.95 | $0.92 | 854 | 04-22-2024 |
$1.01 | $1.09 | $1.01 | $1.24 | $1.01 | 974 | 04-19-2024 |
$0.76 | $0.76 | $0.76 | $0.76 | $0.76 | 225 | 04-18-2024 |
$0.76 | $0.9 | $0.76 | $0.9263 | $0.76 | 20,224 | 04-17-2024 |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Warrant Company Name:
LEXXW Stock Symbol:
NASDAQ Market:
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg se...
(TheNewswire) Kelowna, British Columbia – May 8, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that human pilot study...
KELOWNA, BC / ACCESSWIRE / May 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study part...